B Impact Report

Logo for Chiesi Group

Chiesi Group

Pharmaceutical Products
Certified Since: May, 2019
Location: Parma, Parma, Italy
Sector: Manufacturing

Overall B Impact Scoreinfo_outline

87.5

The B Impact Scores are being compared against all businesses that have completed the B Impact Assessment

The Chiesi history begins in Parma (Italy), where in 1935 Giacomo Chiesi established the first Chiesi-owned laboratory. Today, Chiesi is an international group, with almost 85 years of experience and a strong focus on research and development, production and commercialisation of innovative therapeutic solutions in pulmonology, neonatology, rare diseases and special care. Still owned by the Chiesi family, with nearly 6,000 people employed in 28 countries, Chiesi provides medicines to patients in more than 80 nations.
In December 2018, Chiesi became a Benefit Corporation, thus choosing to adopt a new legal status under US and Italian law. This ensures Chiesi a legal protection to pursue a business model placing social and environmental values on equal footing with profits. With the B Corp Certification, Chiesi reinforces its mission to improve the quality of human life, by acting responsibly towards the society and the environment and by adopting a unified standard of measurement within all the affiliates. Chiesi recognizes to itself a new and active role as member of the communities in which it operates for the benefit of the common good, testimonial of a different way of conceiving the role of business which takes into consideration the needs and challenges of all stakeholders.

Impact Area Scoresinfo_outline